What does CYDAR, Cabinet Médical du Dr. J. Rafati do?

CYDAR, Cabinet Médical du Dr. J. Rafati is a specialist medical practice in Sint-Lambrechts-Woluwe. Private Limited, started on 1 December 2011, 1 establishment.

What is the address of CYDAR, Cabinet Médical du Dr. J. Rafati?

The registered office of CYDAR, Cabinet Médical du Dr. J. Rafati is located at Haagbeukenlaan 8 box 19, 1200 Sint-Lambrechts-Woluwe.

Is CYDAR, Cabinet Médical du Dr. J. Rafati still active?

Yes. According to the CBE (16 September 2026) CYDAR, Cabinet Médical du Dr. J. Rafati is active, legal situation “Normale toestand”, started on 1 December 2011.

Is CYDAR, Cabinet Médical du Dr. J. Rafati registered on Peppol?

Yes, CYDAR, Cabinet Médical du Dr. J. Rafati is registered on the Peppol network with ID 0208:0841471535.

What is the enterprise number of CYDAR, Cabinet Médical du Dr. J. Rafati?

The enterprise number of CYDAR, Cabinet Médical du Dr. J. Rafati is BE0841471535.

When was CYDAR, Cabinet Médical du Dr. J. Rafati founded?

CYDAR, Cabinet Médical du Dr. J. Rafati was founded on 1 December 2011.

Who are the directors of CYDAR, Cabinet Médical du Dr. J. Rafati?

According to the 2025 annual accounts, the directors of CYDAR, Cabinet Médical du Dr. J. Rafati are: Jafar RAFATI.

Is CYDAR, Cabinet Médical du Dr. J. Rafati a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 December 2011; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CYDAR, Cabinet Médical du Dr. J. Rafati make in 2025?

CYDAR, Cabinet Médical du Dr. J. Rafati posted a profit after taxes of € 29,567 in financial year 2025.

What is the revenue of CYDAR, Cabinet Médical du Dr. J. Rafati?

As a small company, CYDAR, Cabinet Médical du Dr. J. Rafati is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 41,147.

CYDAR, Cabinet Médical du Dr. J. Rafati (Private Limited)

Dossier CYDAR, Cabinet Médical du Dr. J. Rafati, printed on 16 September 2026 from databakkes.be/en/0841471535/cydar-cabinet-medical-du-dr-j-rafati. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

CYDAR, Cabinet Médical du Dr. J. Rafati from Sint-Lambrechts-Woluwe, company number BE0841471535, closed financial year 2025 with a result of € 29,567 after tax. For that financial year CYDAR, Cabinet Médical du Dr. J. Rafati recorded a gross margin of € 41,147 and equity of € 43,827. Compared with financial year 2024, the result moved from € 49,740 to € 29,567. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Growing

€ 43,827

▲ 207% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 29,567

▼ 41% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 41,146

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 31,427.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 3,996

▲ 75% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 9,993

▼ 60% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 11,335 Gross margin 2022: € 11,335 First fiscal year in the series	€ 9,664 Gross margin 2023: € 9,664 ▼ 15% vs 2022 (€ 11,335) Unfavourable step	€ 65,781 Gross margin 2024: € 65,781 ▲ € 56,118 vs 2023 (€ 9,664) Favourable step	€ 41,147 Gross margin 2025: € 41,147 ▼ 37% vs 2024 (€ 65,781) Unfavourable step	▼ 37%
Profit after taxes	€ 7,740 Profit after taxes 2022: € 7,740 First fiscal year in the series	€ 5,939 Profit after taxes 2023: € 5,939 ▼ 23% vs 2022 (€ 7,740) Unfavourable step	€ 49,740 Profit after taxes 2024: € 49,740 ▲ € 43,801 vs 2023 (€ 5,939) Favourable step	€ 29,567 Profit after taxes 2025: € 29,567 ▼ 41% vs 2024 (€ 49,740) Unfavourable step	▼ 41%
Equity	€ 14,260 Equity 2022: € 14,260 First fiscal year in the series	€ 14,260 Equity 2023: € 14,260 Unchanged (€ 14,260) Unchanged	€ 14,260 Equity 2024: € 14,260 Unchanged (€ 14,260) Unchanged	€ 43,827 Equity 2025: € 43,827 ▲ 207% vs 2024 (€ 14,260) Favourable step	▲ 207%
Total debts	€ 20,236 Total debts 2022: € 20,236 First fiscal year in the series	€ 9,115 Total debts 2023: € 9,115 ▼ 55% vs 2022 (€ 20,236) Favourable step	€ 60,047 Total debts 2024: € 60,047 ▲ € 50,932 vs 2023 (€ 9,115) Unfavourable step	€ 10,154 Total debts 2025: € 10,154 ▼ 83% vs 2024 (€ 60,047) Favourable step	▼ 83%
Cash	€ 23,792 Cash 2022: € 23,792 First fiscal year in the series	€ 5,916 Cash 2023: € 5,916 ▼ 75% vs 2022 (€ 23,792) Unfavourable step	€ 41,128 Cash 2024: € 41,128 ▲ € 35,212 vs 2023 (€ 5,916) Favourable step	€ 41,146 Cash 2025: € 41,146 Unchanged (€ 41,128) Favourable step
Retained profit	€ 1,860 Retained profit 2022: € 1,860 First fiscal year in the series	€ 1,860 Retained profit 2023: € 1,860 Unchanged (€ 1,860) Unchanged	€ 1,860 Retained profit 2024: € 1,860 Unchanged (€ 1,860) Unchanged	€ 31,427 Retained profit 2025: € 31,427 ▲ € 29,567 vs 2024 (€ 1,860) Favourable step	▲ € 29,567
Dividend	€ 8,131 Dividend 2022: € 8,131 First fiscal year in the series	€ 5,939 Dividend 2023: € 5,939 ▼ 27% vs 2022 (€ 8,131) Unchanged	€ 49,740 Dividend 2024: € 49,740 ▲ € 43,801 vs 2023 (€ 5,939) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 49,740) Unchanged	▼ 100%
Balance sheet total	€ 34,496 Balance sheet total 2022: € 34,496 First fiscal year in the series	€ 23,375 Balance sheet total 2023: € 23,375 ▼ 32% vs 2022 (€ 34,496) Unchanged	€ 74,307 Balance sheet total 2024: € 74,307 ▲ 218% vs 2023 (€ 23,375) Unchanged	€ 53,980 Balance sheet total 2025: € 53,980 ▼ 27% vs 2024 (€ 74,307) Unchanged	▼ 27%

Key figures of CYDAR, Cabinet Médical du Dr. J. Rafati, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CYDAR, Cabinet Médical du Dr. J. Rafati?

What happened at CYDAR, Cabinet Médical du Dr. J. Rafati in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 27, 2026 New annual accounts for financial year 2025: profit of € 29,567 (▼ 41% vs 2024). Source: NBB ↗
Dec 1, 2011 Start of the company according to the CBE. KBO
Nov 17, 2011 New establishment in Sint-Lambrechts-Woluwe. KBO

In short

From € 7,740 profit in 2022 to € 29,567 profit in 2025.

Paid € 28,626 in corporate taxes since 2022.

Best year ever: 2024, with € 49,740 profit.

Paid out € 63,810 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at CYDAR, Cabinet Médical du Dr. J. Rafati? We notify you, reason included.

Follow CYDAR, Cabinet Médical du Dr. J. Rafati

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jafar RAFATI

CYDAR, Cabinet Médical du Dr. J. Rafati

Behind CYDAR, Cabinet Médical du Dr. J. Rafati is Jafar RAFATI.

See the full network in the app

Directors

According to the 2025 annual accounts

Jafar RAFATI

Managing director

Establishments

Establishment units

Physical locations of this company

Registered office

Haagbeukenlaan 8 box 19

1200 Sint-Lambrechts-Woluwe

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

Europa Gym

€ 211,226 gross margin · 2025

Association des copropriétaires du Pavillon XVI entrée n° 8 de l'immeuble sis 1200 Woluwe-Saint-Lambert, Avenue de la Charmille 8

AM & COMPANY

€ 19,192 revenue · 2024

CY & D - DENTAL

AtomCare Nuclear Medicine

€ 201,024 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0841.471.535
VAT number: BE 0841.471.535
Registered office: Haagbeukenlaan 8 bus 19, 1200 Sint-Lambrechts-Woluwe
Names & denominations: CYDAR, Cabinet Médical du Dr. J. Rafati
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 December 2011
Peppol: Active · Active since 24 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗